Lineage Cell Therapeutics (LCTX) Non Operating Investment Income (2010 - 2026)
Lineage Cell Therapeutics (LCTX) recorded Non Operating Investment Income of $24,000 in Q1 2026, compared with -$5,000 a year earlier.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Non Operating Investment Income (2010 - 2026) Analysis & Trends
For FY2025, Lineage Cell Therapeutics reported Non Operating Investment Income of -$8,000.
- Across earlier years, Non Operating Investment Income came in at -$8,000 in FY2024, -$176,000 in FY2023, -$2.19 million in FY2022 and $6.02 million in FY2021 (+32.1%).
- The Q1 2026 figure is the highest quarterly Non Operating Investment Income since Q1 2023.
- Per Business Quant, the preceding three quarters came in at -$7,000 (Q4 2025), $6,000 (Q3 2025) and -$2,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Lineage Cell Therapeutics | 235.20 Mn | 33.61 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 24,000.00 |
| Dec 31, 2025 | -7,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | -6,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Jun 30, 2023 | -150,000.00 |
| Mar 31, 2023 | 40,000.00 |
| Dec 31, 2022 | -517,000.00 |
| Sep 30, 2022 | -233,000.00 |
| Jun 30, 2022 | -709,000.00 |
| Mar 31, 2022 | -735,000.00 |
| Sep 30, 2021 | -2.45 Mn |
| Jun 30, 2021 | 590,000.00 |
| Mar 31, 2021 | 6.02 Mn |
API Access
Lineage Cell Therapeutics Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();